ICCM PE Ratio & Valuation, Is ICCM Overvalued

Historical Valuation

Icecure Medical Ltd (ICCM) is now in the Undervalued zone, suggesting that its current forward PS ratio of 4.00 is considered Undervalued compared with the five-year average of -5.55. The fair price of Icecure Medical Ltd (ICCM) is between 0.94 to 2.28 according to relative valuation method. Compared to the current price of 0.67 USD , Icecure Medical Ltd By Undervalued By 28.62%.

Relative Value

Fair Zone

0.94-2.28

Current Price：0.67

28.62%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Icecure Medical Ltd (ICCM) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Icecure Medical Ltd (ICCM) has a current Price-to-Book (P/B) ratio of 4.67. Compared to its 3-year average P/B ratio of 6.09, the current P/B ratio is approximately -23.28% higher. Relative to its 5-year average P/B ratio of 5.89, the current P/B ratio is about -20.78% higher. Icecure Medical Ltd (ICCM) has a Forward Free Cash Flow (FCF) yield of approximately -31.73%. Compared to its 3-year average FCF yield of -26.99%, the current FCF yield is approximately 17.57% lower. Relative to its 5-year average FCF yield of -24.10%, the current FCF yield is about 31.67% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for ICCM competitors is 2.95, providing a benchmark for relative valuation. Icecure Medical Ltd Corp (ICCM.O) exhibits a P/S ratio of 4.00, which is 35.61% above the industry average. Given its robust revenue growth of 28.40%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of ICCM increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of ICCM in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is ICCM currently overvalued or undervalued?

What is Icecure Medical Ltd (ICCM) fair value?

ICCM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Icecure Medical Ltd (ICCM) is between 0.94 to 2.28 according to relative valuation method.

How does ICCM's valuation metrics compare to the industry average?

The average P/S ratio for ICCM's competitors is 2.95, providing a benchmark for relative valuation. Icecure Medical Ltd Corp (ICCM) exhibits a P/S ratio of 4.00, which is 35.61% above the industry average. Given its robust revenue growth of 28.40%, this premium appears sustainable.

What is the current P/B ratio for Icecure Medical Ltd (ICCM) as of Mar 12 2026?

As of Mar 12 2026, Icecure Medical Ltd (ICCM) has a P/B ratio of 4.67. This indicates that the market values ICCM at 4.67 times its book value.

What is the current FCF Yield for Icecure Medical Ltd (ICCM) as of Mar 12 2026?

As of Mar 12 2026, Icecure Medical Ltd (ICCM) has a FCF Yield of -31.73%. This means that for every dollar of Icecure Medical Ltd's market capitalization, the company generates -31.73 cents in free cash flow.

What is the current Forward P/E ratio for Icecure Medical Ltd (ICCM) as of Mar 12 2026?

As of Mar 12 2026, Icecure Medical Ltd (ICCM) has a Forward P/E ratio of -5.73. This means the market is willing to pay $-5.73 for every dollar of Icecure Medical Ltd's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Icecure Medical Ltd (ICCM) as of Mar 12 2026?

As of Mar 12 2026, Icecure Medical Ltd (ICCM) has a Forward P/S ratio of 4.00. This means the market is valuing ICCM at $4.00 for every dollar of expected revenue over the next 12 months.

ICCM Valuation